Quantitative determination method for hepatitis b virus specificity cell toxicity T lymphocyte
A technology of hepatitis B virus and lymphocytes, which is applied in the field of immunoassay, can solve the problems that need to be further improved, achieve reliable results, reduce non-specific binding, and reduce the effect of background staining
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] Embodiment 1: detection process of the present invention
[0047] 1. Marking of HLA-A2 and HLA-A24 gene subtypes: the purpose is to conduct preliminary screening of HLA-A2 and HLA-A24 gene subtypes in patients with hepatitis B, and the detection is carried out according to the instructions: the method is to add different Fluorescein thiocyanate (FITC)-labeled mouse anti-human immunoglobulin G1 (IgG1)- and phycoerythrin (PE)-labeled mouse anti-human IgG1 10 μl each, the reagents are all products of BD Company in the United States; in the detection tube Add 10 μl of mouse anti-human HLA-A2-FITC (the reagent is the product of BD Pharmingen, USA) and 10 μl of mouse anti-human HLA-A24-PE (the reagent is the product of Japan MBL Company) respectively, and incubate at 22-25°C in the dark 20-30min, with 3ml 0.01M pH 7.2 phosphate buffered saline (PBS) containing 0.1% bovine serum albumin (bovine serum albumin, BSA), centrifuge at 500g for 5min, discard the supernatant, then sha...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com